Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study
10.1159/000506070
Saved in:
Main Authors: | Venketasubramanian, Narayanaswamy, Moorakonda, Rajesh B., Lu, Qingshu, Chen, Christopher L.H., Purabi, Sharma |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
S. Karger AG
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/189106 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
NeuroAid II (MLC901) in Haemorrhagic Stroke
by: Chai-Hoon Nowel Tan, et al.
Published: (2021) -
The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES) for the NEURITE investigators
by: Chen, C.L.H., et al.
Published: (2014) -
Efficacy and safety of MLC601 (NeuroAiD®), a traditional chinese medicine, in poststroke recovery: A systematic review
by: Siddiqui, F.J., et al.
Published: (2014) -
NeuroAiD (R) (MLC601) and Amyloid Precursor Protein Processing
by: Lim, YA, et al.
Published: (2021) -
Association between Baseline NIHSS Limb Motor Score and Functional Recovery after Stroke: Analysis Based on a Multicountry Dataset
by: Chen C.L.H., et al.
Published: (2022)